APOE and diabetes mellitus: Although there is some evidence suggesting a protective impact of diabetes medication on cognition [58], this could also be a chance finding as the increased number of APOE4 alleles in the non-diabetes group and the relatively small size of the group with diabetes may both contribute to the observed protective findings.